Cover Image
Market Research Report

Rest of the World Factor VIII Deficiency Treatment Market, by Product Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Published by Coherent Market Insights Product code 920720
Published Content info 273 Pages
Delivery time: 2-3 business days
Price
Back to Top
Rest of the World Factor VIII Deficiency Treatment Market, by Product Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
Published: January 3, 2020 Content info: 273 Pages
Description

Title:
Rest of the World Factor VIII Deficiency Treatment Market, by Product Type (Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Biologic (Hemlibra), and Desmopressin), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (Latin America, Asia Pacific, Middle East & Russia, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027.

Hemophilia, a factor VIII deficiency is a genetic disorder that is caused by the absence of factor VIII, which is a clotting protein. Moreover, it is genetically passed down to the offspring and according to the National Hemophilia Foundation, in 2019 about 1/3 cases of factor VIII deficiency occurs due to spontaneous mutation in the gene of the parents. Rising incidences and prevalence of hemophilic disorder are expected to boost growth of the market over the forecast period which leads to product launches in the market by the key players, to fulfill the unmet need of the market. Favorable regulatory scenarios and guidelines for the product launches and treatment are another leading factors that are expected to propel growth of the market over the forecast period.

Furthermore, adoption of inorganic strategies by market players such as collaborations to develop the novel therapies for the treatment is also expected to fuel growth of the factor VIII deficiency treatment market over the forecast period. For instance, in July 2019, Sangamo Therapeutics, Inc., a genomic medicine company, and Pfizer, Inc. announced updated results from the Phase 1/2 Alta study evaluating investigational SB-525 gene therapy for severe hemophilia A

Market Dynamics:

Factor VIII deficiency treatment market is expected to witness significant growth over the forecast period, owing to increasing number of hemophilic cases. For instance, according to the World Federation of Hemophilia 2017 statistics, in India, around 18,353 people suffered from hemophilia and 15,218 people were diagnosed with hemophilia A in 2016, out of which around 83.0% had factor VIII deficiency. Moreover, according to the World Federation of Hemophilia reports published in 2017, there were around 10,000 patients with hemophilia A in Brazil. With reference to prior data, World Federation of Hemophilia also reports that in 2017, Brazil had the third largest hemophilia patient population.

Product approvals by the regulatory authorities is expected to drive the growth of factor VIII deficiency treatment market over the forecast period. For instance, in 2019 February, the U.S. Food and Drug Administration approved the biologics license application of Novo Nordisk's long-acting recombinant factor VIII product, N8-GP Turoctocog alfa pegol (Esperoct), for prevention and treatment of individuals with hemophilia A. Moreover, in 2016 March, the U.S. Food and Drug Administration approved Kedrion's, Koate Double Viral Inactivation (DVI) Antihemophilic Factor (human) with Mix2Vial, for the treatment of factor VIII deficiency.

Major players are also focused on adopting inorganic growth strategies such as acquisitions, which is expected to fuel the market growth over the forecast period. For instance, in 2018, CSL Behring acquired China-based plasma-derived therapies manufacturer, Wuhan Zhong Yuan Rui De Biological Products Co. Ltd. From Humanwell Healthcare Group Co. Ltd. The acquisition has expanded CSL's presence in China's domestic plasma fractionation market. It has also enabled CSL to expand their commercial footprint and contributing their expertise for benefit of patients with rare diseases in China.

Key features of the study::

  • This report provides in-depth analysis of the factor VIII deficiency treatment market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2019 -2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the rest of the world factor VIII deficiency treatment market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as part of this study include Baxter International, Inc., Biogen, Inc., Bayer AG, CSL Behring, Ferring B.V., F. Hoffmann-La Roche AG, Pfizer, Inc., Kedrion, and Novo Nordisk A/S
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics
  • The global factor VIII deficiency treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the factor VIII deficiency treatment market.

Detailed Segmentation::

  • Rest of the World Factor VIII Deficiency Treatment Market, By Product Type:
    • Plasma Derived Coagulation Factor Concentrates
    • Recombinant Coagulation Factor Concentrates
    • Biologic (Hemlibra)
    • Desmopressin
  • Rest of the World Factor VIII Deficiency Treatment Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Rest of the World Factor VIII Deficiency Treatment Market, By Region:
    • Latin America
      • By Product Type:
      • Plasma Derived Coagulation Factor Concentrates
      • Recombinant Coagulation Factor Concentrates
      • Biologic (Hemlibra)
      • Desmopressin
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Colombia
      • Rest of Latin America
    • Asia Pacific
      • By Product Type:
      • Plasma Derived Coagulation Factor Concentrates
      • Recombinant Coagulation Factor Concentrates
      • Biologic (Hemlibra)
      • Desmopressin
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • ASEAN
      • Indonesia
      • Malaysia
      • Philippines
      • Singapore
      • Thailand
      • Rest of ASEAN Countries
      • Australia
      • South Korea
      • Pakistan
      • Rest of Asia Pacific
    • Middle East & Russia
      • By Product Type:
      • Plasma Derived Coagulation Factor Concentrates
      • Recombinant Coagulation Factor Concentrates
      • Biologic (Hemlibra)
      • Desmopressin
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • GCC
      • Saudi Arabia
      • United Arab Emirates
      • Israel
      • Russia
      • Turkey
      • Rest of Middle East
    • Africa
      • By Product Type:
      • Plasma Derived Coagulation Factor Concentrates
      • Recombinant Coagulation Factor Concentrates
      • Biologic (Hemlibra)
      • Desmopressin
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • North Africa
      • Algeria
      • Egypt
      • Tunisia
      • Central Africa
      • South Africa
  • Company Profiles
    • Baxter International, Inc*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Biogen, Inc.
    • Bayer AG
    • CSL Behring
    • Ferring B.V.
    • F. Hoffmann-La Roche AG
    • Pfizer, Inc.
    • Kedrion
    • Novo Nordisk A/S

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Developments
  • New Therapy Developments
  • Epidemiology
  • Regulatory Scenario
  • Regulatory Guidelines
  • Reimbursement Scenario
  • PEST Analysis
  • Product Launch
  • PEST Analysis

4. Rest of the World Factor VIII Deficiency Treatment Market, By Product Type, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Plasma Derived Coagulation Factor Concentrates
    • Introduction
    • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Million and Thousand Units)
  • Recombinant Coagulation Factor Concentrates
    • Introduction
    • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Million and Thousand Units)
  • Biologic (Hemlibra)
    • Introduction
    • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Million and Thousand Units)
  • Desmopressin
    • Introduction
    • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Million and Thousand Units)

5. Rest of the World Factor VIII Deficiency Treatment Market, By Distribution Channel, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Rest of the World Factor VIII Deficiency Treatment Market, By Region, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2027
  • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2027, ((US$ Million) and Volume (Thousand Units)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size (US$ Million), Volume (Thousand Units) and Forecast, and Y-o-Y Growth, By Country, 2016-2027)
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of Latin America
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million) and Volume (Thousand Units)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size (US$ Million), Volume (Thousand Units) and Forecast, and Y-o-Y Growth, By Country, 2016-2027)
    • China
    • India
    • Japan
    • ASEAN
    • Indonesia
    • Malaysia
    • Philippines
    • Singapore
    • Thailand
    • Rest of ASEAN Countries
    • Australia
    • South Korea
    • Pakistan
    • Rest of Asia Pacific
  • Middle East & Russia
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Russia
    • Turkey
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million) and Volume (Thousand Units)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size (US$ Million), Volume (Thousand Units) and Forecast, and Y-o-Y Growth, By Country/Region, 2016-2027)
    • North Africa
    • Algeria
    • Egypt
    • Tunisia
    • Central Africa
    • South Africa

7. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Baxter International, Inc.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Biogen, Inc.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Bayer AG
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • CSL Behring
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Ferring B.V.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • F. Hoffmann-La Roche AG
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Pfizer, Inc.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Kedrion
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Novo Nordisk A/S
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top